ENTITY

Novo Nordisk (NVO US)

93
Analysis
Health Care â€Ē Denmark
Novo Nordisk A/S develops, produces, and markets pharmaceutical products. The Company focuses on diabetes care and offers insulin delivery systems and other diabetes products. Novo Nordisk also works in areas such as haemostatis management, growth disorders, and hormone replacement therapy. The Company offers educational and training materials. Novo Nordisk markets worldwide.
more
bullishâ€ĒCom7
â€Ē22 Jan 2025 09:58â€ĒBroker

Today's Dominant Ideas

Technically, the SET Index is expected to rise, with the resistance at 1,360/1,364 points and the support at 1,343/1,338 points. Investors are...

Logo
90 Views
Share
â€Ē09 Aug 2024 10:22â€ĒBroker

Today's Dominant Ideas

Technically, the SET Index is expected to move sideways up, with the resistance at 1,301/1,306 points (25-day EMA) and the support at 1,287/1,281...

Logo
99 Views
Share
bullishâ€ĒLenovo
â€Ē24 Feb 2025 17:38â€ĒBroker

Global Market Update: February 24, 2025

āļ”āļąāļŠāļ™āļĩ CSI 300 āđāļĨāļ° HSI āļ›āļĢāļąāļšāļ•āļąāļ§āđƒāļ™āļāļĢāļ­āļšāđāļ„āļšāļāđˆāļ­āļ™āļ›āļīāļ”āļĨāļ”āļĨāļ‡ āđ‚āļ”āļĒāļŦāļļāđ‰āļ™āļ›āļĢāļąāļšāļ‚āļķāđ‰āļ™āļĨāļ‡āļ•āļēāļĄāļ›āļąāļˆāļˆāļąāļĒāđ€āļ‰āļžāļēāļ°āļ•āļąāļ§ āđ€āļĢāļēāļĄāļ­āļ‡āļœāļĨāļ›āļĢāļ°āļāļ­āļšāļāļēāļĢ 2025 āļĄāļĩāđāļ™āļ§āđ‚āļ™āđ‰āļĄāđ€āļ•āļīāļšāđ‚āļ•āļ•āļēāļĄāļāļĢāļ°āđāļŠāļāļēāļĢāļĨāļ‡āļ—āļļāļ™ Data...

Logo
86 Views
Share
bearishâ€ĒBCPG
â€Ē06 Feb 2025 10:08â€ĒBroker

Krungthai XSpring Zoom Eng.

Technically, the SET Index is expected to move in a sideways-down pattern, with the support at 1,280/1,273 points and the resistance at...

Logo
87 Views
Share
â€Ē24 Dec 2024 10:02â€ĒBroker

Cabinet Meeting and New Year Gift Measures

Technically, the SET Index is expected to move sideways up, with the resistance at 1,394/1,403 points (10-day EMA) and the support at 1,380/1,374...

Logo
87 Views
Share
x